RUBIUS THERAPEUTICS INC (RUBY) Forecast, Price Target & Analyst Ratings

NASDAQ:RUBY • US78116T1034

Current stock price

0.083 USD
-0.04 (-33.55%)
At close:
0.0899 USD
+0.01 (+8.31%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RUBIUS THERAPEUTICS INC (RUBY).

Forecast Snapshot

Consensus Price Target

Price Target
$1.02
+ 1,128.92% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 8, 2023
Period
Q1 / 2023
EPS Estimate
-$0.24
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.02
Upside
+ 1,128.92%
From current price of $0.08 to mean target of $1.02, Based on 7 analyst forecasts
Low
$1.01
Median
$1.02
High
$1.05

Price Target Revisions

1 Month
0.00%
3 Months
-90.48%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for RUBY. The average price target is 1.02 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.083.
The average price target has been revised downward by 90.48% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RUBY Current Analyst RatingRUBY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

RUBY Historical Analyst RatingsRUBY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
RUBY was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about RUBY.
In the previous month the buy percentage consensus was at a similar level.
RUBY was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-09-13GuggenheimDowngrade Buy -> Neutral
2022-09-09Morgan StanleyMaintains Equal-Weight
2022-08-09SVB LeerinkMaintains Market Perform
2022-05-11Morgan StanleyMaintains Equal-Weight
2022-05-11HC Wainwright & Co.Maintains Buy
2022-05-10SVB LeerinkMaintains Market Perform
2022-04-11GuggenheimMaintains Buy
2022-04-11SVB LeerinkMaintains Market Perform
2022-04-11Morgan StanleyMaintains Equal-Weight
2022-04-11HC Wainwright & Co.Maintains Buy
2022-02-25SVB LeerinkMaintains Market Perform
2021-11-09SVB LeerinkMaintains Market Perform
2021-05-18Morgan StanleyMaintains Equal-Weight
2021-04-19Morgan StanleyMaintains Equal-Weight
2021-03-15SVB LeerinkMaintains Market Perform
2021-03-15HC Wainwright & Co.Maintains Buy
2021-02-23SVB LeerinkMaintains Market Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 8, 2023
Period
Q1 / 2023
EPS Estimate
-$0.24
Revenue Estimate
N/A
Revenue Q2Q
N/A
EPS Q2Q
57.79%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

RUBY is expected to report earnings on 5/8/2023. The consensus EPS estimate for the next earnings is -0.24 USD and the consensus revenue estimate is null USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2018 2019 2020 2021 2022 2023
Revenue
YoY % growth
RUBY revenue by date.RUBY revenue by date.
N/A
EBITDA
YoY % growth
RUBY ebitda by date.RUBY ebitda by date.
-10.73M-42.81M
-298.97%		-90.4M
-111.17%		-166.6M
-84.29%		-160.76M
3.51%		-186.893M
-16.26%		-120.995M
35.26%		N/A
27.50%
EBIT
YoY % growth
RUBY ebit by date.RUBY ebit by date.
-10.85M-43.26M
-298.71%		-91.66M
-111.88%		-169.6M
-85.03%		-166.45M
1.86%		-194.616M
-16.92%		-127.249M
34.62%		N/A
30.70%
Operating Margin
RUBY operating margin by date.RUBY operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
RUBY eps by date.RUBY eps by date.
N/AN/AN/A-2.07
-16.13%		-2.08
-0.48%		-2.23
-7.21%		N/A
16.52%		N/A
64.38%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.24
57.79%		-0.26
47.96%		-0.27
26.33%		-0.26
18.03%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RUBY Yearly EPS VS EstimatesRUBY Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RUBIUS THERAPEUTICS INC / RUBY Forecast FAQ

What is the average price target for RUBIUS THERAPEUTICS INC (RUBY) stock?

7 analysts have analysed RUBY and the average price target is 1.02 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.083.

Can you provide the upcoming earnings date for RUBIUS THERAPEUTICS INC?

RUBIUS THERAPEUTICS INC (RUBY) will report earnings on 2023-05-08.

What is the consensus rating for RUBIUS THERAPEUTICS INC (RUBY) stock?

The consensus rating for RUBIUS THERAPEUTICS INC (RUBY) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.